18 Patents
- US125530922026Energetic Cancer Stem Cells (E-CSCS): a New Hyper-metabolic and Proliferative Tumor Cell Phenotype, Driven by Mitochondrial Energy
LUNELLA BIOTECH, Inc.
0 cites - US123589202025Substituted Pyrrolo[2,3-d]pyrimidines as Selective CDK 4/6 Inhibitors
LUNELLA BIOTECH, Inc.
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
- US118651242024Vitamin C and Doxycycline: a Synthetic Lethal Combination Therapy for Eradicating Cancer Stem Cells (CSCS)
LUNELLA BIOTECH, Inc.
0 cites - US118651302024Antimitoscins: Targeted Inhibitors of Mitochondrial Biogenesis for Eradicating Cancer Stem Cells
LUNELLA BIOTECH, Inc.
0 cites - US117380342023Triphenylphosphonium-derivative Compounds for Eradicating Cancer Stem Cells
LUNELLA BIOTECH, Inc.
0 cites - US116728102023Therapeutics and Methods for Predicting and Overcoming Endocrine Resistance in Breast Cancer
LUNELLA BIOTECH, Inc.
0 cites - US116676392023Mitoketoscins: Mitochondrial-based Therapeutics Targeting Ketone Metabolism in Cancer Cells
LUNELLA BIOTECH, Inc.
0 cites - US116676402023Mitoketoscins: Mitochondrial-based Therapeutics Targeting Ketone Metabolism in Cancer Cells
LUNELLA BIOTECH, Inc.
0 cites - 0 cites
- 0 cites
- US115476792023Mitoriboscins: Mitochondrial-based Therapeutics Targeting Cancer Cells, Bacteria and Pathogenic Yeast
LUNELLA BIOTECH, Inc.
0 cites